NovoCure Ltd’s recent filing unveils that its Chief Innovation Officer Weinberg Uri unloaded Company’s shares for reported $5071.0 on Mar 03 ’25. In the deal valued at $18.92 per share,268 shares were sold. As a result of this transaction, Weinberg Uri now holds 166,243 shares worth roughly $3.22 million.
Then, Leonard Frank X sold 2,527 shares, generating $46,841 in total proceeds. Upon selling the shares at $18.54, the EVP, Pres., Novocure Oncology now owns 143,673 shares.
Before that, Cordova Ashley sold 2,053 shares. NovoCure Ltd shares valued at $38,055 were divested by the Chief Executive Officer at a price of $18.54 per share. As a result of the transaction, Cordova Ashley now holds 204,005 shares, worth roughly $3.95 million.
Evercore ISI upgraded its NovoCure Ltd [NVCR] rating to an Outperform from a an In-line in a research note published on December 02, 2024; the price target was increased to $30 from $18. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in mid October from “a Neutral” to “a Buy”. H.C. Wainwright revised its rating on August 28, 2023. It rated NVCR as “a Neutral” which previously was an “a Buy”.
Price Performance Review of NVCR
On Tuesday, NovoCure Ltd [NASDAQ:NVCR] saw its stock fall -1.17% to $19.36. Over the last five days, the stock has lost -9.19%. NovoCure Ltd shares have fallen nearly -35.03% since the year began. Nevertheless, the stocks have risen 32.51% over the past one year. While a 52-week high of $34.13 was reached on 01/02/25, a 52-week low of $11.70 was recorded on 03/04/25. SMA at 50 days reached $23.24, while 200 days put it at $20.69.
Levels Of Support And Resistance For NVCR Stock
The 24-hour chart illustrates a support level at 18.98, which if violated will result in even more drops to 18.60. On the upside, there is a resistance level at 19.60. A further resistance level may holdings at 19.83. The Relative Strength Index (RSI) on the 14-day chart is 38.88, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.11, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 49.16%. Stochastics %K at 48.26% indicates the stock is a holding.
How much short interest is there in NovoCure Ltd?
A steep rise in short interest was recorded in NovoCure Ltd stocks on 2025-02-28, growing by 0.24 million shares to a total of 5.22 million shares. Yahoo Finance data shows the prior-month short interest on 2025-01-31 was 4.97 million shares. There was a rise of 4.69%, which implies that there is a positive sentiment for the stock.
